articleTop 1% cited
Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
American Journal of Ophthalmology · 2008 · Vol. 145(2) · pp. 239–248.e5
Carl D. Regillo✉(Wills Eye Hospital)David M. Brown(Houston Methodist)Prema Abraham(Black Hills Regional Eye Institute)Huibin YueTsontcho IanchulevSusan SchneiderNaveed Shams
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic ConditionsRanibizumabMedicineMacular degenerationChoroidal neovascularizationOphthalmologyAdverse effectVisual acuityRandomized controlled trialSurgeryBevacizumab
MeSH terms
RanibizumabAgedAged, 80 and overAntibodies, MonoclonalDouble-Blind MethodFemaleHumansInjectionsMacular DegenerationMaleMiddle AgedVisual AcuityVitreous BodyTreatment OutcomeChoroidal Neovascularization
Citations
860
FWCI
76.19
field-weighted impact
References
13
Percentile
100%
vs. same field & year
Citations per year
Cited by
Macular Thickness Measurements in Healthy Eyes Using Six Different Optical Coherence Tomography Instruments
Investigative Ophthalmology & Visual Science · 2009 · 425 citations
Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
Ophthalmology · 2011 · 700 citations
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
British Journal of Ophthalmology · 2014 · 633 citations
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
Ophthalmology · 2013 · 801 citations
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
American Journal of Ophthalmology · 2009 · 882 citations
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
British Journal of Ophthalmology · 2014 · 602 citations
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Ophthalmology · 2012 · 2,431 citations
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Ophthalmology · 2019 · 886 citations
References
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin
Archives of Ophthalmology · 1999 · 2,186 citations
An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration
American Journal of Ophthalmology · 2007 · 969 citations
A sharper Bonferroni procedure for multiple tests of significance
Biometrika · 1988 · 4,717 citations
Signs and Symptoms of Uveitis
American Journal of Ophthalmology · 1959 · 526 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.